Edgewell Personal Care (EPC) reported fourth-quarter earnings of $0.68 per share, significantly missing the Zacks Consensus Estimate of $0.82 and declining from $0.72 a year prior. While quarterly revenue of $537.2 million slightly surpassed expectations and increased year-over-year, the company has consistently failed to meet EPS estimates over the last four quarters. This underperformance, alongside a 43.7% year-to-date stock decline and an unfavorable estimate revision trend, has resulted in a Zacks Rank #4 (Sell), indicating potential continued underperformance, exacerbated by the Consumer Products - Staples industry's low ranking.
Edgewell Personal Care (EPC) reported Q4 earnings of $0.68 per share, significantly missing the Zacks Consensus Estimate of $0.82 by 17.07% and declining from $0.72 year-over-year. This marks the fourth consecutive quarter the company has failed to surpass consensus EPS estimates. While quarterly revenues of $537.2 million slightly exceeded the Zacks Consensus Estimate by 0.22% and grew from $517.6 million a year ago, the company has only topped revenue estimates once in the last four quarters. The stock has experienced substantial underperformance, losing 43.7% year-to-date compared to the S&P 500's 16.5% gain. This poor performance, coupled with an unfavorable trend in earnings estimate revisions, has resulted in a Zacks Rank #4 (Sell) for EPC, indicating an expectation of near-term market underperformance. Further compounding the company's challenges, the Consumer Products - Staples industry, to which EPC belongs, is currently ranked in the bottom 22% of Zacks industries. This sector-wide weakness suggests broader headwinds that could continue to materially impact EPC's performance, despite any company-specific efforts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment
